Publications To Date

    NANOSTRING PUBLICATIONS

    Filter Publications

    PAGE 5 OF 95 | DISPLAYING 61 - 75 OF 1412 RESULTS

    Wolfe AR et al., A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection., , Oncotarget, Mar 10, 2020

    Shin W et al., Application of NanoString technologies in angioimmunoblastic T cell lymphoma., , Genes Genomics, Mar 07, 2020

    Ontario Health Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment., , Ont Health Technol Assess Ser, Mar 06, 2020

    Dingerdissen HM et al., OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy Data., , JCO Clin Cancer Inform, Mar 06, 2020

    Nafia I et al., IDO Targeting in Sarcoma: Biological and Clinical Implications., , Front Immunol, Mar 05, 2020

    Salerno D et al., Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription, , Gut, Feb 29, 2020

    Kok VC et al., Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer., , Front Oncol, Feb 28, 2020

    Dang HX et al., Long non-coding RNA LCAL62 / LINC00261 is associated with lung adenocarcinoma prognosis , , Heliyon, Feb 28, 2020

    Das Mahapatra K et al., A comprehensive analysis of coding and non-coding transcriptomic changes in cutaneous squamous cell carcinoma., , Sci Rep, Feb 27, 2020

    Jensen MB et al., The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients, , npj Breast Cancer, Feb 26, 2020

    Nirschl TR et al., Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulation., , Am J Clin Exp Urol, Feb 25, 2020

    Thorne AH et al., Adjuvant Screen Identifies Synthetic DNA-Encoding Flt3L and CD80 Immunotherapeutics as Candidates for Enhancing Anti-tumor T Cell Responses., , Front Immunol, Feb 25, 2020

    Pinato DJ et al., Programmed cell death ligands expression drives immune tolerogenesis across the diverse subtypes of neuroendocrine tumours, , Neuroendocrinology., Feb 25, 2020

    Cimadamore A et al., Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view., , Expert Opin Biol Ther., Feb 25, 2020

    Pessôa-Pereira D et al., miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil., , BMC Cancer., Feb 22, 2020